Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Borrowed familiar targets make kill unrelated new immune cells

In , newly activated borrow familiar and become targets. Blocking recognition of those borrowed labels would restore and without extra .

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Biological function

Cytotoxic T cells provide protection by recognizing antigen-bearing target cells and killing them. This includes maintaining responses to previously encountered antigens and establishing persistent T-cell populations capable of killing targets bearing newly encountered antigens.Antigen-specific T-cell protection

Direction

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Lens
Cytotoxic target misattribution
Goal
Repertoire Renewal–Retention Competition and Selectivity Failure Resistance
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Receptor or channel

    Peptide–MHC complexes

    Peptide–MHC complexes are cell-surface complexes recognized by

    Where this hypothesis actsAcquired familiar complexes on newly activated cells while are active

    Hypotheses on this target 1
    Peptide–MHC complexesLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 11Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade1
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Block recognition of acquired familiar

    With whatNot stated in the record

    HowSelectively mask acquired familiar complexes on recipient cells while retaining established recall protection

    Possible result

    Possible restoration of unfamiliar-cell and

    From the recordSelectively blocking recognition of the acquired familiar complex on unfamiliar cells will restore their post-contraction persistence and target-specific killing without increasing maintenance support.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Phosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαPeptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexes
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Restoring an ageing immune system means building protection against new threats while keeping protection already learned. The unexpected move is that new defenders might be killed because they borrow surface labels that existing defenders recognize as targets. That mistaken identity is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Familiar-first exposure activates established killers before new defenders pass through their proposed label-borrowing interval.
  2. Cells displaying material for immune recognition pass familiar surface labels to newly activated defenders with unrelated recognition targets.
  3. Borrowed labels turn those new defenders from unrelated bystanders into recognizable targets for established killers.
  4. Established killers eliminate labelled new defenders, reducing the population that survives after the response subsides.
  5. Unfamiliar-first exposure could let the borrowing interval end before established killing activity peaks.
  6. Selectively hiding borrowed labels is predicted to preserve new defenders without increasing the resources available to sustain them.
A picture for it

A worker accidentally picks up a badge marked for removal, and a guard acts on the badge rather than the worker's identity. Whether the mistake matters depends on whether the guard is present while the worker wears it.

Where the picture breaks: Immune recognition is a physical interaction between cells, not a deliberate identity check. The picture does not establish that unrelated new defenders acquire enough familiar labels, retain them long enough, or encounter killers at the required time.

  1. Master questionstep 01 of 04

    People with age-related immune decline need lasting recovery of both , the body's broadly acting defenses, and , its defenses tailored to particular targets. The goal is function within healthy young-adult ranges while retaining learned protection, avoiding attacks on the body's own tissues, and keeping persistent dormant infections controlled.

    Rests on: The goal itself requires restoration and preservation together: improved responses cannot count as full recovery if established protection or control of harmful responses is lost.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Renewing the , the collection of distinct targets immune cells can recognize, must coexist with retaining established protection and resisting failures to distinguish appropriate targets.

    Rests on: The master question explicitly combines restored immune function with preservation of learned protection and avoidance of attacks on the body's own tissues. The pillar names renewal, retention, competition and selection as its focus without explaining their relationship.

    Stated in the chain
  3. Gap questionstep 03 of 04

    The order of familiar and unfamiliar exposures might determine whether a new , a cell family descended from a with a particular recognition target, persists despite identical total , sleep loss and nutrient availability. is material recognized by the immune system. The proposed boundary is a , a population-model boundary between conditions that allow a rare population to grow and conditions that do not.

    Rests on: The preceding pillar identifies competition between renewal and retention, but supplies no explanation connecting to a particular population-model threshold.

    Leap

    Neither the preceding text nor the screened sources supplies the connection from matched exposure totals and different to this threshold, or establishes that this model describes unfamiliar-cell .

  4. Hypothesisstep 04 of 04

    Newly activated , immune cells that can develop the ability to kill recognized targets, are proposed to acquire familiar labels: protein fragments held in surface display molecules. , which display such fragments for immune recognition, would supply those labels. , defenders responding to a previously encountered target, would then kill these new cells despite their unrelated recognition targets. Familiar-first exposure is proposed to put killers in place during the borrowing interval; unfamiliar-first exposure could let that interval end before killing peaks. Preventing this targeting error is proposed to preserve new defenders while retaining established protection.S2S3S4

    Rests on: The gap supplies the problem; the screened literature supplies precedents for borrowing surface labels and for immune cells killing other immune cells. Cell Metabolism (2022) reports transfer of target-associated display complexes to activated , but does not establish transfer to unrelated new cells from or their killing by . A European Journal of Immunology abstract (2005) reports killing between mouse cells sharing the same recognition target at concentrations above those needed for full activation; it does not establish killing across unrelated recognition targets or an effect. PLOS ONE (2013) reports that , immune cells that support other immune cells, can use acquired display complexes to stimulate new ; it does not establish the proposed borrowing-and-killing sequence.

    Supported by literature

What is carried, and what is not. The screened sources speak to two component links: transfer of surface recognition labels and killing between immune cells. Their different cell types and recognition relationships do not establish the proposed sequence end to end, its dependence on , or its operation in cultures from aged donors.

Where the reasoning is carried by something unstated · 1
  • Gap question. Neither the preceding text nor the screened sources supplies the connection from matched exposure totals and different to this threshold, or establishes that this model describes unfamiliar-cell . Establish the missing link before relying on this step.
How a result here could mislead · 3
  • New cells dying after contact with could be read as proof that borrowed labels caused the killing, even if label acquisition merely accompanies activation or the cells' own respond to familiar material. are the molecules through which cells recognize targets. What closes it: Traceable labels and time-lapse observation must establish acquisition before death. The test must also verify that unfamiliar-cell do not respond to familiar material and that selectively hiding acquired labels reduces killing while leaving the intended unfamiliar-target response available.
  • Disabling killing could preserve new cells simply by suppressing established protection. That would not establish a selective correction of mistaken targeting. What closes it: The proposed general disruption of killing can support a role for killing but cannot demonstrate preservation of protection. That claim requires the technically demanding intervention that hides labels only on recipient new cells, alongside measurement of retained recall killing.
  • More new cells surviving at the end could be credited to preventing mistaken targeting even if the intervention changed initial activation, cell multiplication or access to sustaining resources. An early loss of every could also explain lasting absence. What closes it: Follow survival and descendant numbers through time, measure label-dependent deaths, and hold the stated exposure totals, hormonal schedules, nutrients and abundance matched. The proposed recovery must include both survival after the response subsides and killing of the intended target; the supplied design gives no numerical success criterion.

What would make this wrong. The proposal specifies rejection if acquired familiar labels do not cause recall-mediated killing and an intervention aimed at a rival explanation successfully restores unfamiliar-cell . Such absence is informative only if label acquisition, active recall killing and the ability to detect deaths were verified; otherwise a failed test could reflect failure to create or observe the proposed conditions.

What it would change. If the hypothesis held, immune renewal could require preventing established defenders from mistakenly eliminating new ones, alongside supplying conditions for their survival. Work toward restoring youthful immune function would need to distinguish this targeting error from competition for sustaining resources and from other causes of early loss. Even a successful aged-donor culture test would not establish durable restoration in people, recovery of broadly acting defenses, avoidance of attacks on the body's own tissues, or control of dormant infections. The named outcome is not defined in the supplied material, so its claimed stabilization cannot be translated into a specific restoration criterion.

Sources read · 3

4 literature searches, 2 full texts, 2 abstract-only; 4 source(s) read in full against this question. A bounded search is not evidence of absence.

S2Partly answers it

ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes. · Cell metabolism · 2022

“The effector trogocytosis between activated CD8+ T cells (cytotoxic T lymphocytes, CTLs) and target cells expressing specific antigen leads to a transfer of MHC-antigen complexes onto CTLs”

Does not settle: This source does not establish transfer from antigen-presenting cells to newly activated unrelated-specificity CD8 cells, recall-cell targeting of those cells, exposure-order effects, selective predation versus maintenance-capacity competition, or SPV_7 stabilization.

S3Partly answers itAbstract only

T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells. · European journal of immunology · 2005

“Interestingly, fratricide (i.e., killing between CTL sharing the same specificity), a mechanism proposed to account for CTL exhaustion, was detected only at antigen concentrations still well above that second threshold leading to full blown activation.”

Does not settle: This abstract reports mouse CTL models and fratricide among CTL sharing the same specificity. It does not establish exposure-order effects, killing of unrelated newly activated CD8 cells bearing acquired familiar peptide–MHC, maintenance-capacity competition, SPV_7, or prevention of such targeting errors.

S4Background

Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways. · PloS one · 2013

“We showed that APC-stimulated CD4 + helper T (Th) cells are able to stimulate naïve CD8 + T cells via acquired peptide-major histocompatibility complex-I (pMHC-I) complexes, inducing central memory CTL stimulation and anti-tumor immunity.”

Does not settle: This source does not establish that newly activated CD8 cells acquire peptide–MHC complexes, that recall cytotoxic cells kill such cells, the effect of exposure order, or whether selective killing rather than maintenance-capacity competition determines exclusion.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Can changing make immune-cell families targeting unfamiliar threats persist or disappear despite identical total exposures and resources?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does switch across a even when total , sleep loss, and nutrient availability are identical?

What this question is asking

The question concerns whether the sequence of exposures changes which families of immune cells remain available to recognize unfamiliar threats. It asks whether changing that sequence, while holding the total amount of , sleep loss, and nutrient availability identical, changes whether those families persist. It frames that change as crossing a , assuming that a mathematical boundary between successful establishment and failure describes this immune system. The larger distinction is between a temporary redistribution of immune responses and permanent loss of the ability to recognize particular threats. The stated requirement also includes recovery into predefined ranges between repeated cycles, without accumulating deficits or progressively slower recovery over ten years.

What the terms mean
Exposure order
The sequence in which exposures occur. The question changes this sequence while requiring the specified totals and resource conditions to remain identical.
Antigen
A substance or molecular feature recognized by the immune system. Matching total means matching its overall amount, although the supplied material does not specify how amounts from different exposures are compared.
Immune-cell clone or clonotype
A family of immune cells grouped by shared ancestry or recognition identity. In this question, of such a family is distinct from the size of its response at one measurement.
Unfamiliar clone
The question's label for an immune-cell family associated with an unfamiliar target. The supplied material does not define what makes a target unfamiliar or how that label is assigned to a family.
Specificity or recognition ability
The particular target or targets an immune response can recognize. Loss of one cell family and loss of a recognition ability are separate claims; the supplied material does not establish their equivalence.
Persistence
Continued presence of a cell family over time. The supplied material does not give the duration, minimum abundance, or measurement needed to count a family as persisting.
Lotka–Volterra model
A class of mathematical models describing how interacting populations change in size. Its use here is a proposed way to describe competition among immune-cell families, rather than evidence that a particular biological threshold exists.
Invasion threshold
A model boundary separating conditions in which a rare population can initially increase from conditions in which it cannot. Initial increase alone does not establish long-term or irreversible loss.
Calibrated threshold
A proposed boundary whose parameters have been tied to measurements in the relevant system. No numerical or measured boundary for this question is supplied.
T cell
A type of immune cell involved in recognizing targets and coordinating or carrying out immune responses. S1 models competition among families of these cells sharing stimuli.
Stimuli
Signals or inputs that influence cells. S1 says the modeled families share stimuli, but the supplied quotation does not specify those inputs.
Antigenic competition
Interaction between responses to different , such that one response can affect another. The term alone does not establish that causes lasting loss of an immune-cell family.
Antibody-producing cells
Immune cells that release proteins able to bind particular targets. S9 measures cells whose antibody activity is associated with destruction of red blood cells in the study's test.
Nude mice
Mice with impaired development, used in the comparison reported by S9. They are a particular animal model, not a direct representation of in people.
Inbred guinea-pig strain
A guinea-pig breeding line with a closely shared genetic background. S10 identifies strain 2 as its experimental animal population.
Immune surveillance
Immune-system activity that recognizes and acts against abnormal cells. S2 places competition among cancer-cell families in this setting.
Liver colonization
The ability of cancer cells to establish themselves in the liver. This is the outcome described in S2, distinct from of immune-cell families.
Age-related immune dysfunction
Changes associated with aging that impair immune performance. It names a broad set of possible problems, rather than one uniform cell state or single measurement.
Recovery bands
Predefined ranges that measurements must return to for recovery to count as achieved. The gap detail requires such ranges between cycles but supplies neither the measurements nor their boundaries.
Clock misalignment
A mismatch involving the body's daily timing rhythms and the timing of activities or exposures. The gap detail mentions models of this process without supplying their findings.
What the question takes for granted
Premise could not be checked
is governed by a that could cross.

An immune-cell clone is a family of cells sharing a particular recognition identity, and the question concerns families associated with unfamiliar threats. The named mathematical model describes interacting populations, with an invasion threshold representing a boundary at which a rare population can begin to establish itself. Treating that boundary as applicable would allow a change in to be interpreted as a switch in rather than merely a change in response size.

S1 reports a model of competition among multiple families sharing stimuli, and S4 mentions analogies between immune-network equations and Lotka–Volterra equations. Neither establishes the proposed threshold for . The supplied source set is too indirect to determine whether that threshold framing is valid in the system being asked about; it neither establishes nor refutes it.S1S4

The same question asked without the part nothing read establishes:

  • Does changing alter of immune-cell families targeting unfamiliar threats when total , sleep loss, and nutrient availability are identical?
  • Under those matched conditions, are differences in recognition of unfamiliar threats temporary or persistent?
What turns on the answer
  • Order switches Under the proposed mechanism, changing the sequence would move an immune-cell family from conditions allowing establishment to conditions preventing it, or the reverse. Equal total exposures and resources would then be insufficient to establish equal preservation of recognition abilities. Such an outcome would still not, by itself, establish irreversible loss or recovery over ten years.
  • Order changes responses temporarily Sequence could change the size or distribution of immune responses while the affected families remain capable of recovering. A short-term reduction would then be insufficient evidence of permanent loss of recognition. The stated recovery requirement would turn on whether responses return to the predefined ranges between cycles.
  • Order does not change With the specified totals and resources matched, the compared sequences would leave unchanged. would then not explain a difference under those conditions. This outcome would not establish that overall immune function had recovered or remained stable for ten years.
Why it matters

If exposure sequence changes whether an immune-cell family persists, equal total exposures could leave different abilities to recognize unfamiliar threats. If an apparent loss instead reflects a temporary redistribution, an early measurement could mistake recoverable change for permanent loss. Conversely, a short-lived recovery in overall response could fail to establish that every affected recognition ability has returned. The distinction therefore affects whether the stated requirement for repeated recovery over ten years has actually been met; the supplied sources do not establish that chain of outcomes.

What is already established

RL-1 competition and models suggest mechanisms; RL-2 exposure monitoring records timing but establishes neither nor durable recovery.

What would have to be true

must return to between cycles, without cumulative deficits or progressively longer recovery over ten years.

What is missing

No distinguishes temporary allocation changes from irreversible loss under combined ordinary-life .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

determines whether newly activated cells acquire familiar from while are active. These acquired complexes make unfamiliar cells targets for recall-mediated killing despite their unrelated . The dominant exclusion mechanism is therefore on falsely labelled , rather than competition for . Familiar-first exposure establishes killers before unfamiliar acquire the misleading labels; unfamiliar-first exposure can allow the vulnerable to end before recall killing peaks. Preventing this targeting error would stabilize while retaining established recall protection.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

In with matched totals, hormonal schedules, nutrients and abundance, unfamiliar cells displaying acquired familiar will undergo -contact-associated . Selectively blocking recognition of the acquired familiar complex on unfamiliar cells will restore their and without increasing . The effect should remain when unfamiliar show no to familiar . Absence of acquired-complex-dependent killing, together with successful through another rival's intervention, would reject this explanation.

Would tell it apart from at least one rival. The prediction specifies observable apoptosis, functional rescue following selective recognition blockade, persistence of the effect without TCR cross-reactivity, and an explicit rejection condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

recall and populations can be distinguished with and . Traceable and can establish acquisition before death. is technically demanding; provides an but is not itself a clinically acceptable strategy because it disables protective .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

In with matched totals, hormonal schedules, nutrients and abundance, unfamiliar cells displaying acquired familiar will undergo -contact-associated . Selectively blocking recognition of the acquired familiar complex on unfamiliar cells will restore their and without increasing . The effect should remain when unfamiliar show no to familiar . Absence of acquired-complex-dependent killing, together with successful through another rival's intervention, would reject this explanation.

  • What would separate them

    Exposure order blocks unfamiliar immune cells through receptor-specific inhibitory signals predicts: With unfamiliar , and , familiar variants that retain equivalent recall stimulation but move outside the unfamiliar independently mapped will abolish the order-dependent deficit. Increasing nutrients or preventing will not abolish that deficit. of the on standardized should reproduce the effect without . Failure of independently mapped to predict susceptible would reject the .

  • What would separate them

    Exposure order can cause chance loss of unfamiliar immune cells despite favorable average growth predicts: Across many with the same unfamiliar , sequence and environmental schedule, will vary probabilistically despite a positive . Increasing the initial number of otherwise identical unfamiliar will sharply reduce complete loss while leaving measured , recall abundance and recognition unchanged. Under an independently acting , P_loss(n,T) = q(T)^n, where n is initial number and q(T) is one 's probability of leaving no at T. A nearly loss that remains after -number increases would favor the or targeted-killing rivals.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

The primary study [ mediates to limit ](https://pmc.ncbi.nlm.nih.gov/articles/PMC9057587/) connects acquired -bearing membrane material with . It establishes a relevant capability, not the proposed aging mechanism.

Subfield revised

and models would need to revise the textbook chapter on generation and maintenance of : successful recall could actively delete unrelated new through acquired target identity, even with adequate survival support.

Testable surprise

A would eliminate newly recruited, protective solely because those cells temporarily display borrowed familiar ; masking that borrowed identity would recover unfamiliar protection while leaving recall abundance and unchanged.

Why this is not the mainstream account

A targeted literature search found established -associated , but no source establishing acquired familiar on unrelated unfamiliar as the dominant cause of age-associated . This supports provisional novelty of the specific dominance claim, not proof that no review or perspective has ever proposed it.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Emerging role of microRNAs as modulators of the tumor immune microenvironment.; Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer.; Immune Cytolytic Activity Correlates with Tumor Microenvironmental Aberrations in Colorectal Cancer..

6 papers retrieved around this hypothesis
  • Iron Dyshomeostasis and Divergent Antigen Presentation Remodeling in Bronchiectasis: A Dual-Dataset Transcriptomic Analysis.PMID 42670432 · full_text · 50,005 characters stored
  • Immune Cytolytic Activity Correlates with Tumor Microenvironmental Aberrations in Colorectal Cancer.PMID 42511524 · full_text · 109,277 characters stored
  • Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer.PMID 42092363 · full_text · 96,708 characters stored
  • Emerging role of microRNAs as modulators of the tumor immune microenvironment.PMID 42350044 · full_text · 82,705 characters stored
  • Single-cell dissection of hepatocellular carcinoma immunity: from heterogeneous subtypes to precision therapeutics.PMID 41756301 · full_text · 117,968 characters stored
  • Epigenetic reprogramming in autoimmune and immune-mediated skin disease.PMID 42719601 · full_text · 154,935 characters stored

0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.